Main > A1. CORP. INDEX. G-Gm > Genentech/P C2

---

This data is not available for free

Genentech/P C2's subsections
2000. 04.17.2000. (Parent of)
2000. 04.24.2000. (NanoTech.)
2000. 07.31.2000. (Blood Coag.)
2000. 07.31.2000. (Inflammation)
2000. 09.18.2000. (GH Delivery)
2000. 10.16.2000. (Was Partner in)
2001. 05.08.2001. (Allergy/Asthma)
2002. 04.22.2002. (Contract Mfg)
2002. 04.29.2002. (Ab-Drug Conj.)
2002. 04.29.2002. (Immunology)
2002. 05.06.2002. (Lawsuit Revived)
2002. 05.13.2002. (Oncology)
2002. 05.20.2002. (IFN-Gamma)
2002. 06.03.2002. (BioTech.)
2002. 06.03.2002. (GH Production)
2002. 06.17.2002. (Royalty Dispute)
2002. 07.01.2002. (Royalty Dispute)
2002. 08.19.2002. (Oncology)
2002. 09.16.2002. (Oncology)
2002. 09.23.2002. (Patent Expir.)
2002. 11.04.2002. (DeMerger)
2002. 12.02.2002. (Oncology)
2002. 12.09.2002. (Contract Mfg.)
2003. 01.27.2003. (Dermatology)
2003. 02.24.2003. (IFN-Alpha)
2003. 03.17.2003. (Allergy/Asthma)
2003. 05.19.2003. (Oncology)
2003. 06.09.2003. (Stock = $73)
2003. 06.17.2003. (Rheumatology)
2003. 06.22.2003. (Allergy/Asthma)
2003. 06.23.2003. (Licensee)
2003. 08.15.2003. (Allergy/Asthma)
2003. 09.17.2003. (Oncology)
2003. 12.22.2003. (PDL Agreement)
2004. 02.26.2004. (Oncology)
2005. 01.24.1995. (Drug Target..)
2005. 06.27.2005. (Plant Acq)
2005. 10.24.2005. (Onco. Deal)
2006. 02.27.2006. (Lonza)
2006. 07.25.2006. Inotek Pharma.
2006. 10.30.2006. VP Small Molecule
2006. 11.07.2006. (Lonza)
2006. 11.16.2006. (Onco.>Breast C.)
2007. 04.02.2007. (Singapore)
2007. 11.18.2007. (Onco.>Brain C.)
2008. 02.25.2008. (Cabilly Patent)
2008. 03.07.2008. (Onco.>NSCLC)
2009. 03.09.2009. (CEO)
2009. 03.09.2009. (CFO)
2009. 03.16.2009. (Acq. By:)
2009. 05.11.2009. Ex. VP Research &
2009. 05.11.2009. Research & Early
2010. 02.18.2010. UCSF>Neuro.
2010. 07.12.2010. MRC Technology
2011. 02.24. Onco.>Breast C. B+P
2011. 04.11. Onco.>PI3K Inh.
2012. 01.13. Ophthalmo>Wet AMD
2012. 01.30. Onco.>Skin Cancer
2012. 08.10. Ophthalmo>DME
2013. 01.23. Onco.>Colon C.
2013. 03.02. Onco.>NSCLC
2013. 04.30. Rheuma.>PJIA IV
2013. 09.27. Onco.>Breast C. T-DM1
2013. 10.10. Derma.>CIU (CSU)
2013. 10.21. Rheuma.>RA
2013. 11.07. Onco.>Leukemia>CLL
2014. 05.31. Onco.>Bladder C.
2014. 07.01. Acq. Seragon Pharma.
2014. 08.14. Onco.>Cervical C.
2014. 09.28. Onco.>Breast C. P
2014. 11.14. Onco.>Ovarian C.
2015. 02.06. DME>DR
2015. 11.10. Onco.>Melanoma C+Z
2016. 05.18. Onco.>Bladder C.
2017. 01.05. Ophthalmo.>mCNV
2017. 03.28. Neuro.>MS
2017. 11.06. Onco.>NSCLC
2017. 11.16. Hemato.>Hemophilia A
2017. 11.16. Onco.>Lymphoma
2017. 12.20. Onco.>Breast C. P
2018. 05.14. Rheuma.>PJIA SC
2018. 11.27. Acq. Jecure Therapeuti
2018. 12.05. Onco.>NSCLC
2019. 03.08. Onco.>Breast C. T
2019. 05.03. Onco.>Breast C.
2019. 05.15. Onco.>CLL/SLL
2019. 06.10. Onco.>DLBCL
2019. 08.15. Onco.>NSCLC & NTRK
2019. 12.03. Onco.>NSCLC
2020. 03.18. COVID-19
2020. 03.23. COVID-19
2020. 05.18. Onco.>NSCLC>USA>OK
2020. 05.29. Onco.>Liver C.
2020. 07.30. Onco.>Melanoma>T+C+Z
2020. 08.07. SMA>Risdiplam>USA>OK
2020. 08.14. Neuro.>NMOSD
2020. 12.01. Nasal Polyps
2020. 12.14. Neuro.>MS
2021. 04.15. SMA>Risdiplam>CA>OK
2021. 10.22. Ophthalmo.>Wet AMD
2022. 01.28. Ophthalmo.>Wet AMD &
2022. 12.21. COVID 19>USA>OK
2022. 12.22. Onco.>FL>USA>OK
2023. 04.19. Onco.>DLBCL>FDA>OK
2023. 06.15. Onco.>DLBCL>FDA>OK
Patents
Web Site
Z - OK

Genentech/P C2's products
This section has no products